Filing Details

Accession Number:
0001209191-17-047762
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-04 17:46:11
Reporting Period:
2017-08-02
Filing Date:
2017-08-04
Accepted Time:
2017-08-04 17:46:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1625101 Pulse Biosciences Inc. PLSE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1507650 Maky Zanganeh 3957 Point Eden Way
Hayward CA 94545
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-02 8,290 $25.15 287,225 No 4 P Direct
Common Stock Acquisiton 2017-08-03 6,000 $23.23 293,225 No 4 P Direct
Common Stock Acquisiton 2017-08-03 9,500 $23.89 302,725 No 4 P Direct
Common Stock Acquisiton 2017-08-03 5,000 $23.00 90,474 No 4 P Indirect Dependent Minor
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Indirect Dependent Minor
Footnotes
  1. This is the weighted average purchase price of the shares, which ranged from $24.97 to $25.25 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  2. This is the weighted average purchase price of the shares, which ranged from $22.80 to $23.79 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  3. This is the weighted average purchase price of the shares, which ranged from $23.80 to $24.04 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  4. This is the weighted average purchase price of the shares, which ranged from $22.78 to $23.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.